Anti-pancreatic cancer vasculogenic mimicry agents are inadequate, so Palmitoyl-DL-carnitine chloride (PC) was explored as a Protein kinase C (PKC) inhibitor in the MIA PaCa-2 pancreatic cancer cell line. Here, PRRT2 is linked to pancreatic neoplasm.